1. Cairns JA: Coronary thrombolysis – overwhelming evidence for mortality reduction in acute myocardial infarction. Can J Cardiol. 1988, 4 (5): 211-3.
2. Walker DM, Wicks M, Hubbard WN, Thomas RD: Increased mortality from inadequate provision of coronary care unit facilities. J R Soc Med. 1994, 87 (4): 211-2.
3. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986, 1 (8478): 397-402.
4. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group: Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988, 2 (8607): 349-60.
5. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico: GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet. 1990, 336 (8707): 65-71.